Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Eli Lilly's drive to provide as many treatment ... the launch of new high-dose vials sold at a $150 discount to its auto-injector versions. The company is adding 7.5mg and 10mg vials of Zepbound ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

If you assume that Lilly and Novo Nordisk continue to dominate ... They've started to offer, instead of just the auto injector pens, they've offered the drugs and vials at reduced prices.

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Eli Lilly Chief Executive David Ricks annual compensation rose to $29.2 million in 2024, a 10% increase from the $26.2 million he received a year earlier. Ricks' payout included $19.7 million in ...

1,2 The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company (NYSE: LLY). Launched in 2022, the ...